← FDA Drug Approvals (Drugs@FDA)
CARBIDOPA AND LEVODOPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-11-12
Drug application
- FDA Application #
ANDA219989- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBIDOPA AND LEVODOPA
- Generic name
- Carbidopa, Levodopa
- Active ingredients
- CARBIDOPA, LEVODOPA
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- SANDOZ INC
- First approval
- 2025-11-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown